Search filters

List of works by Katherine K Matthay

124I-MIBG PET-CT to monitor metastatic disease in children with relapsed neuroblastoma

scientific article published on 15 May 2020

131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study.

scientific article published on 30 January 2015

131I‐MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma ⬇️

scientific article published on September 28, 2012

A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma

scientific article

A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study

scientific article published on 01 October 2007

A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group

scientific article

A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma

scientific article

A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study

scientific article

A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group

scientific article published on July 1997

Acute changes in blood pressure in patients with neuroblastoma treated with ¹³¹I-metaiodobenzylguanidine (MIBG).

scientific article published on 23 April 2013

Advances in Risk Classification and Treatment Strategies for Neuroblastoma

scientific article

Adverse impact of regional lymph node involvement in osteosarcoma.

scientific article published on 15 July 2013

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas

article

Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma

article

Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.

scientific article published in November 1994

An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy

scientific article

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

scientific article

Antineuronal Antibodies in Patients With Neuroblastoma and Paraneoplastic Opsoclonus-Myoclonus

article

Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group

scientific article published on 11 July 2017

Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma

scientific article published on 13 December 2020

Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study

scientific article published in March 2000

Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study

scientific article published on January 2000

Bone marrow in children with acute lymphocytic leukemia: MR relaxation times

scientific article published on 01 July 1986

Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients

scientific article

Changes in Children’s Reports of Symptom Occurrence and Severity During a Course of Myelosuppressive Chemotherapy ⬇️

scientific article published on August 25, 2010

Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project

scientific article

Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: A report from the INRG project

scientific article published on 01 December 2011

Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis ⬇️

scientific article published on 05 September 2012

Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction

scientific article published on November 2008

Chromosome 1p and 11q deletions and outcome in neuroblastoma

scientific article

Clinical Features and Outcomes Differ between Skeletal and Extraskeletal Osteosarcoma

scientific article

Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project

scientific article

Clinical features and outcomes in patients with extraskeletal Ewing sarcoma

scientific article

Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma

scientific article published on 27 August 2012

Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project

scientific article

Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.

scientific article published on October 2009

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification

scientific article published on 01 March 2001

Comparison of Clinical Features and Outcomes in Patients With Bilateral Versus Unilateral Adrenal Neuroblastoma

scientific article published on 4 November 2016

Comparison of autologous and allogeneic bone marrow transplantation for neuroblastoma.

scientific article published in January 1994

Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma

scientific article published on 05 October 2009

Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group

scientific article

Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment

scientific article published on August 1988

Comprehensive analysis of chromosome 1p deletions in neuroblastoma

article

Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

scientific article published on 21 May 2019

Congenital leukemia: successful treatment of a newborn with t(5;11)(q31;q23).

scientific article

Congenital malformation syndromes associated with peripheral neuroblastic tumors: A systematic review

scientific article published on 02 July 2019

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force

scientific article published on 28 April 2009

Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies

scientific article published in September 1996

Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: efficacy and underlying mechanisms.

scientific article published on 16 April 2011

Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.

scientific article

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

scientific article

Current treatment and outcome for childhood acute leukemia in Tanzania

scientific article

Decreased aortic growth and middle aortic syndrome in patients with neuroblastoma after radiation therapy

scientific article published on 18 September 2009

Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531

scientific article published on 16 November 2018

Diagnostic value of PET/CT for the staging and restaging of pediatric tumors

scientific article

Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma

scientific article published on 01 November 2019

Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG)

scientific article

Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco

scientific article published on July 1996

Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial

scientific article published on 14 June 2012

Drugging MYCN through an allosteric transition in Aurora kinase A

scientific article

Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study

scientific article published on 01 June 2004

Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma.

scientific article published in June 1998

Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index

scientific article

Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group

scientific article

Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastoma

scientific article published in April 1993

Estimation of intra-arterial chemotherapy distribution to the retina in pediatric retinoblastoma patients using quantitative digital subtraction angiography

scientific article published in January 2018

Ethnic and racial differences in patients with Ewing sarcoma

scientific article

Evaluation and Outcome of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia in Dar es Salaam, Tanzania

scientific article

Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group ⬇️

scientific article published on September 25, 2012

Evaluation of plasma annexin V levels in children and young adults with solid tumors ⬇️

scientific article published on July 19, 2012

Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: A report from the childhood cancer survivor study ⬇️

scientific article published on July 25, 2011

Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.

scientific article published in December 2006

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

article

Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy

scientific article published on 01 February 1989

Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis.

scientific article

Extended Sedation With Continuous Midazolam or Dexmedetomidine Infusion for Young Children Receiving 131 I-MIBG Radiopharmaceutical Therapy for Advanced Neuroblastoma.

scientific article

Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study

scientific article published in February 2000

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study

scientific article

Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow

scientific article

Functional and clinical outcomes of limb-sparing therapy for pediatric extremity sarcomas

scientific article published in March 2001

Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization

scientific article published on January 1997

Germline MUTYH Mutation in a Pediatric Cancer Survivor Developing a Secondary Malignancy

scientific article published on 04 December 2019

Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project

scientific article published on 17 May 2011

Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group

scientific article

Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma

scientific article

Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma

scientific article

High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma

scientific article

Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group

scientific article published in November 2001

Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular

scientific article published in September 2000

Identification of Subsets of Neuroblastomas by Combined Histopathologic and N-myc Analysis ⬇️

scientific article published on October 4, 1995

Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project

scientific article published on 28 December 2015

Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group

scientific article published on 09 February 2016

Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG).

scientific article

Impact of radiotherapy for high-risk neuroblastoma: a Children’s Cancer Group study ⬇️

scientific article published on May 1, 2003

Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine.

scientific article

Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma.

scientific article published on August 2006

Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number

scientific article published on 01 June 2006

Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma

scientific article published on 01 January 1991

International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.

scientific article

International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

scientific article published in November 2001

Intraoperative radiation therapy for high-risk pediatric neuroblastoma

scientific article published on July 2000

Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial

Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study

scientific article published on 26 January 2009

Is adjuvant therapy ever warranted in localized neuroblastoma

scientific article published in September 2000

Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastoma

scientific article published on 24 May 2014

Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma

scientific article published on 22 May 2007

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

scientific article

Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study

article

Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) project

scientific article

MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.

scientific article published on 6 April 2017

Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531

scientific article published on 06 August 2019

Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).

scientific article published in August 2006

Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database

scientific article

Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival

scientific article published on May 1999

Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography

scientific article

Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors

scientific article published in December 2000

Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastoma.

scientific article published in January 1994

Neuroblastoma

scientific article published on 10 November 2016

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

scientific article published on 2 October 2017

Neuroblastoma in adults and adolescents: an indolent course with poor survival

scientific article

Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project

scientific article

Neuroblastoma: biology and staging

scientific article

Neuroblastoma: clinical and biological approach to risk stratification and treatment

scientific article published on 23 March 2018

Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells ⬇️

scientific article published on December 2007

Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.

scientific article

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study

scientific article

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.

scientific article

Osteosarcoma in children 5 years of age or younger at initial diagnosis

scientific article

Outcome after reduced chemotherapy for intermediate-risk neuroblastoma

scientific article

Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.

scientific article

Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group

scientific article published on January 2009

Paracrine Signaling Through MYCN Enhances Tumor-Vascular Interactions in Neuroblastoma ⬇️

scientific article published on January 4, 2012

Patient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma

scientific article

Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation

scientific article published on 8 November 2016

Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.

scientific article published in November 1993

Pediatric acute blastic natural killer cell leukemia

scientific article

Pediatric cancer type predicts infection rate, need for critical care intervention, and mortality in the pediatric intensive care unit

scientific article

Pelvic neuroblastoma--implications for a new favorable subgroup: a Children's Cancer Group experience

scientific article published in November 1995

Peripheral Blood Biomarkers Associated With Toxicity and Treatment Characteristics After 131I- Metaiodobenzylguanidine Therapy in Patients With Neuroblastoma

scientific article published on 15 May 2017

Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group

scientific article

Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors

scientific article

Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial

scientific article published on 15 March 2012

Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma

scientific article

Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial

scientific article

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma

scientific article

Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.

scientific article published in January 2006

Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group

scientific article published on December 2008

Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's

scientific article published on 01 December 2000

Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial

scientific article published on 30 March 2018

Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors.

scientific article published in December 2000

Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation

scientific article

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.

scientific article

Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study ⬇️

scientific article published on February 22, 2011

Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study

scientific article

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

scientific article published on 09 August 2018

Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study

scientific article

Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma

scientific article

Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.

scientific article published in March 2007

Physician Perspectives on Palliative Care for Children With Neuroblastoma: An International Context.

scientific article published on 19 January 2016

Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study

scientific article published on 17 October 2011

Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.

scientific article

Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma

scientific article published on April 2002

Poly (ADP-Ribose) polymerase inhibitor MK-4827 together with radiation as a novel therapy for metastatic neuroblastoma

scientific article published on March 2013

Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma

scientific article published on 16 December 2011

Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.

scientific article

Prenatal diagnosis of chronic granulomatous disease

scientific article published on 01 April 1984

Primary bone tumors: value of MR angiography for preoperative planning and monitoring response to chemotherapy

scientific article published in July 1995

Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.

scientific article

Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification

scientific article published in September 2006

Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database

scientific article

Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.

scientific article published on 3 October 2011

Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma ⬇️

scientific article published on October 1, 2011

Promising therapeutic targets in neuroblastoma

scientific article

Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemia

scientific article

Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis

scientific article published in March 2001

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

scientific article published on 25 July 2013

Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.

scientific article published in December 2000

Racial Differences in the Incidence of Mesenchymal Tumors Associated with EWSR1 Translocation ⬇️

scientific article published on January 6, 2011

Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.

scientific article

Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma

scientific article published on August 2008

Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors

scientific article

Reply to N.-K.V. Cheung et al

scientific article published on 17 November 2014

Reply: Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy?

scientific article

Response of neuroblastoma to retinoic acid in vitro and in vivo

scientific article published on January 1991

Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults

scientific article

Retinoid therapy of high-risk neuroblastoma.

scientific article

Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular

scientific article

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting

scientific article published on 4 May 2017

Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk Neuroblastoma

scientific article published on 12 June 2019

Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study

scientific article published on 09 April 2019

SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings

scientific article published on 21 March 2015

Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma

scientific article

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project ⬇️

scientific article published on September 13, 2012

Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group

scientific article

Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database

scientific article published in December 2008

Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.

scientific article

Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study

scientific article published on 20 September 2019

Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy.

scientific article published on 4 May 2009

Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study ⬇️

scientific article published on April 1, 1998

Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution

scientific article published on 27 May 2013

Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems

scientific article published in February 1995

Symptom Cluster Analyses Based on Symptom Occurrence and Severity Ratings Among Pediatric Oncology Patients During Myelosuppressive Chemotherapy ⬇️

scientific article published on January 1, 2012

Symptom assessment in pediatric oncology: how should concordance between children's and parents' reports be evaluated?

scientific article published in July 2014

TMOD-09. HUMAN PLURIPOTENT STEM CELL-BASED MODELS OF NEUROBLASTOMA

scientific article published on 6 November 2017

Targeted Isotretinoin in Neuroblastoma: Kinetics, Genetics, or Absorption ⬇️

scientific article published on December 3, 2012

Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma

scientific article

Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for 131 I-MIBG therapy of neuroblastoma using 124 I-MIBG PET/CT

scientific article published on 12 March 2019

Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma

scientific article published in December 2000

Telomerase expression in primary neuroblastomas

scientific article

The International Neuroblastoma Pathology Classification (the Shimada system).

scientific article

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

scientific article published on December 2008

The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report

scientific article published in December 2008

The International Neuroblastoma Risk Groups (INRG): a preliminary report

scientific article published on October 1997

The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives

scientific article

The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma ⬇️

scientific article published on May 1, 2012

Thyroid and hepatic function after high‐dose 131I‐metaiodobenzylguanidine (131I‐MIBG) therapy for neuroblastoma ⬇️

scientific article published on September 9, 2010

Total body irradiation and bone marrow transplantation for immunodeficiency disorders in young children

scientific article published in January 1990

Toxicities of total-body irradiation for pediatric bone marrow transplantation

scientific article published on March 1996

Transcript Analysis for Internal Biodosimetry Using Peripheral Blood from Neuroblastoma Patients Treated with (131)I-mIBG, a Targeted Radionuclide.

scientific article published on 24 August 2016

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

scientific article

TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance

scientific article

Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.

scientific article

Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma

scientific article

Validation of post-induction Curie scores in high risk neuroblastoma. A Children's Oncology Group (COG) and SIOPEN group report on SIOPEN/HR-NBL1.

scientific article published on 8 September 2017

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.

scientific article

Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.

scientific article published on 4 September 2015

Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems.

scientific article published on 18 March 2011

Paulina is supported by:

About Paulina

Help